Literature DB >> 6138110

[3H]-guanfacine: a radioligand that selectively labels high affinity alpha2-adrenoceptor sites in homogenates of rat brain.

B Jarrott, W J Louis, R J Summers.   

Abstract

[3H]-guanfacine (N-amidino-2-(2,6-dichloro 3[3H] phenyl) acetamide hydrochloride; 24.2 Ci/mmol) has been used as a radioligand in homogenates of rat cerebral cortex. Specific binding of [3H]-guanfacine was linear with respect to tissue concentration (2.5-15 mg/ml), saturable and not markedly affected in the pH range 6.5-8.0. Analysis of the saturation of [3H]-guanfacine binding using an iterative least squares fitting procedure gave best fits to a single site model. [3H]-guanfacine binding was of high affinity (Kd 1.77 +/- 0.24 nM; n = 8) to a population of non interacting sites (nH 0.99 +/- 0.02; n = 8) with a density of 118.2 +/- 8.4 fmol/mg protein (n = 8). Highest levels of binding were achieved in cerebral cortex followed by thalamus greater than hypothalamus greater than medulla/pons greater than spinal cord greater than striatum greater than cerebellum. Binding was stereoselective with regard to the (-)-isomer of noradrenaline and the order of potency for displacement of [3H]-guanfacine by agonists was naphazoline greater than clonidine greater than (-)-adrenaline greater than (-)-alpha methylnoradrenaline greater than (-)-noradrenaline greater than (+/-)-alpha-methylnoradrenaline greater than (+)-noradrenaline greater than methoxamine greater than (+)-adrenaline greater than phenylephrine and by antagonists was phentolamine greater than dihydroergocryptine greater than piperoxane greater than yohimbine greater than prazosin greater than labetalol greater than indoramin suggested binding to alpha 2-adrenoceptors. The monovalent cations Na+ and K+ and also guanosine 5'-triphosphate (GTP) produced concentration-dependent inhibition whereas the divalent cations Ca2+, Mg2+, and Mn2+ first enhanced, then inhibited [3H]-guanfacine binding. Na+ (150 mM) or GTP (100 microM) produced marked reductions and Mn2+ (5 mM) marked increases in the number of receptor sites labelled by [3H]-guanfacine. 9 It is concluded that [3H]-guanfacine preferentially labels a high affinity state of the alpha 2- adrenoceptor in homogenates of rat cerebral cortex.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6138110      PMCID: PMC2071608          DOI: 10.1111/j.1476-5381.1982.tb08801.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  18 in total

1.  Binding characteristics of a radiolabeled agonist and antagonist at central nervous system alpha noradrenergic receptors.

Authors:  D C U'Prichard; D A Greenberg; S H Snyder
Journal:  Mol Pharmacol       Date:  1977-05       Impact factor: 4.436

2.  Simultaneous determination of indole- and catecholamines in small brain regions in the rat using a weak cation exchange resin.

Authors:  R B Holman; P Angwin; J D Barchas
Journal:  Neuroscience       Date:  1976       Impact factor: 3.590

3.  Inhibitory effects of clonidine and BS 100-141 on responses to sympathetic nerve stimulation in cats and rabbits.

Authors:  W Pacha; R Salzmann; G Scholtysik
Journal:  Br J Pharmacol       Date:  1975-04       Impact factor: 8.739

4.  Pharmacology of BS 100-141, a centrally acting antihypertensive drug.

Authors:  K Saameli; G Scholtysik; R Waite
Journal:  Clin Exp Pharmacol Physiol       Date:  1975       Impact factor: 2.557

5.  Multiple alpha 2-noradrenergic receptor sites in rat brain: selective regulation of high-affinity [3H]clonidine binding by guanine nucleotides and divalent cations.

Authors:  B M Rouot; D C U'Prichard; S H Snyder
Journal:  J Neurochem       Date:  1980-02       Impact factor: 5.372

6.  Selectivity of a series of clonidine-like drugs for alpha 1 and alpha 2 adrenoceptors in rat brain.

Authors:  R J Summers; B Jarrott; W J Louis
Journal:  Neurosci Lett       Date:  1980-12       Impact factor: 3.046

7.  Ligand: a versatile computerized approach for characterization of ligand-binding systems.

Authors:  P J Munson; D Rodbard
Journal:  Anal Biochem       Date:  1980-09-01       Impact factor: 3.365

8.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

9.  Pharmacological actions of the antihypertensive agent N-amidino-2-(2,6-dichlorophenyl)acetamide hydrochloride (BS 100-141).

Authors:  G Scholtysik; H Lauener; E Eichenberger; H Bürki; R Salzmann; E Müller-Schweinitzer; R Waite
Journal:  Arzneimittelforschung       Date:  1975-10

10.  Comparison of [3H]clonidine and [3H]guanfacine binding to alpha 2 adrenoceptors in membranes from rat cerebral cortex.

Authors:  R J Summers; B Jarrott; W J Louis
Journal:  Neurosci Lett       Date:  1981-08-07       Impact factor: 3.046

View more
  13 in total

1.  Neurochemical evidence for two types of presynaptic alpha 2-adrenoceptors.

Authors:  J Kapocsi; G T Somogyi; N Ludvig; P Serfozo; L G Harsing; R J Woods; E S Vizi
Journal:  Neurochem Res       Date:  1987-02       Impact factor: 3.996

2.  Guanfacine enhances inhibitory control and attentional shifting in early abstinent cocaine-dependent individuals.

Authors:  Helen Fox; Mehmet Sofuoglu; Rajita Sinha
Journal:  J Psychopharmacol       Date:  2015-01-07       Impact factor: 4.153

3.  Noradrenergic modulation of the medullary respiratory rhythm generator in the newborn rat: an in vitro study.

Authors:  S Errchidi; R Monteau; G Hilaire
Journal:  J Physiol       Date:  1991-11       Impact factor: 5.182

4.  The use of reaction time distributions to study attention in male rats: the effects of atomoxetine and guanfacine.

Authors:  Zach V Redding; Pooja Chawla; Karen E Sabol
Journal:  Psychopharmacology (Berl)       Date:  2019-07-18       Impact factor: 4.530

5.  Antiarrhythmic efficacy of labetalol as assessed by programmed electrical stimulation.

Authors:  G Krumpl; H Todt; K Krejcy; G Raberger
Journal:  Br J Pharmacol       Date:  1990-08       Impact factor: 8.739

6.  The physiological and pharmacological role of presynaptic alpha- and beta-adrenoceptors in man.

Authors:  M J Brown; A D Struthers; J M Burrin; L Di Silvio; D C Brown
Journal:  Br J Clin Pharmacol       Date:  1985-12       Impact factor: 4.335

Review 7.  Clinical pharmacokinetics of labetalol.

Authors:  J J McNeil; W J Louis
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

8.  The recovery of alpha-adrenoceptor function and binding sites after phenoxybenzamine. An index of receptor turnover?

Authors:  C A Hamilton; H W Dalrymple; J L Reid; D J Sumner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-01       Impact factor: 3.000

9.  Evidence for pharmacological similarity between alpha 2-adrenoceptors in the vas deferens and central nervous system of the rat.

Authors:  J C Doxey; B Gadie; A C Lane; I F Tulloch
Journal:  Br J Pharmacol       Date:  1983-09       Impact factor: 8.739

Review 10.  Guanfacine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension.

Authors:  E M Sorkin; R C Heel
Journal:  Drugs       Date:  1986-04       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.